Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vyriad, Inc.

News headline image
Vyriad Secures Final $25M Series B Tranche to Advance In Vivo CAR T Candidate into Clinic
From Vyriad, Inc.
Via Business Wire
News headline image
Vyriad Unveils Lead In Vivo CAR T Candidate VV169 and Data Supporting Future Clinical Development During ASH 2025
From Vyriad, Inc.
Via Business Wire
News headline image
Vyriad and Weizmann Institute of Science Enter Exclusive License Agreement for In Vivo Gene Delivery Technology
From Vyriad, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.